BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6552217)

  • 1. Effect of cycloheximide and of anti-C3 Fab' on the intrinsic synthesis and secretion of lysosomal enzyme and of complement components by guinea-pig peritoneal macrophages.
    Kreuzpaintner G; Brade V
    Immunology; 1983 Jun; 49(2):337-42. PubMed ID: 6552217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of factors D, B and P of the alternative pathway of complement activation, as well as of C3, by guinea-pig peritoneal macrophages in vitro.
    Bentley C; Fries W; Brade V
    Immunology; 1978 Dec; 35(6):971-80. PubMed ID: 104925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional active complement components secreted by guinea pig peritoneal macrophages.
    Brade V; Kreuzpaintner G
    Immunobiology; 1982 Apr; 161(3-4):315-21. PubMed ID: 7047377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages.
    Bentley C; Bitter-Suermann D; Hadding U; Brade V
    Eur J Immunol; 1976 Jun; 6(6):393-8. PubMed ID: 1033069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human monocyte spreading induced by factor Bb of the alternative pathway of complement activation. A possible role for C5 in monocyte spreading.
    Sundsmo JS; Götze O
    J Exp Med; 1981 Sep; 154(3):763-77. PubMed ID: 6912276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3 activation by a new factor B-dependent enzyme detected in culture supernatant from guinea-pig peritoneal macrophages.
    Beuscher HU; Brade V
    Immunology; 1986 Aug; 58(4):545-51. PubMed ID: 3089917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative studies of the secretion of complement component C3 by resident, elicited and activated macrophages. Comparison with C2, C4 and lysosomal enzyme release.
    Zimmer B; Hartung HP; Scharfenberger G; Bitter-Suermann D; Hadding U
    Eur J Immunol; 1982 May; 12(5):426-30. PubMed ID: 7094993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of C3a by a monocarboxypeptidase present in culture supernatants of stimulated guinea pig peritoneal macrophages.
    Kreuzpaintner G; Damerau B; Zimmermann B; Plummer TH; Brade V
    J Immunol; 1986 May; 136(9):3384-9. PubMed ID: 3485689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of activated complement components on enzyme secretion by macrophages.
    Schorlemmer HU; Allison AC
    Immunology; 1976 Nov; 31(5):781-8. PubMed ID: 992710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte complement: interleukin-like properties of factor Bb.
    Hirani S; Fair DS; Papin RA; Sundsmo JS
    Cell Immunol; 1985 May; 92(2):235-46. PubMed ID: 3846490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of gene expression during macrophage activation with a polyribonucleotide. The role of endogenously derived IFN.
    Riches DW; Henson PM; Remigio LK; Catterall JF; Strunk RC
    J Immunol; 1988 Jul; 141(1):180-8. PubMed ID: 3379303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of complement components (C3, C2, B and C1-inhibitor) and lysozyme by human monocytes and macrophages.
    Lappin D; Hamilton AD; Morrison L; Aref M; Whaley K
    J Clin Lab Immunol; 1986 Jul; 20(3):101-5. PubMed ID: 3638367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-treated antigen-antibody complexes inhibit the production of C2 and factor B by mononuclear phagocytes.
    Whaley K; Lappin D; Hamilton AO
    Immunology; 1983 Feb; 48(2):255-63. PubMed ID: 6549747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative determination of complement components produced by purified hepatocytes.
    Ramadori G; Rasokat H; Burger R; Meyer Zum Büschenfelde KH; Bitter-Suermann D
    Clin Exp Immunol; 1984 Jan; 55(1):189-96. PubMed ID: 6692595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-macrophage colony-stimulating factor, but not macrophage colony-stimulating factor, suppresses basal and lipopolysaccharide-stimulated complement factor production in human monocytes.
    Høgåsen AK; Hestdal K; Abrahamsen TG
    J Immunol; 1993 Sep; 151(6):3215-24. PubMed ID: 7690797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of complement components C3 and factor B in human keratinocytes is differentially regulated by cytokines.
    Pasch MC; Van Den Bosch NH; Daha MR; Bos JD; Asghar SS
    J Invest Dermatol; 2000 Jan; 114(1):78-82. PubMed ID: 10620119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor B, the complement alternative pathway serine proteinase, is a major constitutive protein synthesized and secreted by resident and elicited mouse macrophages.
    Sundsmo JS; Chin JR; Papin RA; Fair DS; Werb Z
    J Exp Med; 1985 Feb; 161(2):306-22. PubMed ID: 3844438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human monocyte spreading induced by activated factor B of the complement alternative pathway: differential effects of Fab' and F(ab')2 antibody fragments directed to C5, C6, and C7.
    Sundsmo JS; Götze O
    Cell Immunol; 1983 Apr; 77(1):176-86. PubMed ID: 6601526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of EAC142 and EAC1423 with macrophage culture supernatant containing the secreted complement components C1 to C3.
    Brade V; Beuscher HU
    Immunobiology; 1984 Mar; 166(2):177-89. PubMed ID: 6724636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.